{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:57:08Z","timestamp":1782932228734,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["1017493"],"award-info":[{"award-number":["1017493"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005993","name":"University of Michigan Institute for Research on Women and Gender","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.urolonc.2025.07.017","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T11:13:04Z","timestamp":1755169984000},"page":"664.e1-664.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostate-specific antigen screening among transgender women in clinical care: A retrospective chart review study"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-8877","authenticated-orcid":false,"given":"Ashley","family":"Lacombe-Duncan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi Celia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Saucier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goodhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2025.07.017_bib0001","first-page":"12","article-title":"Recent trends in prostate cancer in Canada","volume":"30","author":"LeBlanc","year":"2019","journal-title":"Health Rep"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0002","unstructured":"Canadian Cancer Society. Prostate cancer statistics. 2024. Available from: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/prostate\/statistics Accessed March 27, 2024."},{"key":"10.1016\/j.urolonc.2025.07.017_bib0003","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0004","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/QAI.0000000000001088","article-title":"Integrated and gender-affirming transgender clinical care and research","volume":"72","author":"Reisner","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0005","doi-asserted-by":"crossref","first-page":"bvab011","DOI":"10.1210\/jendso\/bvab011","article-title":"Hormone therapy, mental health, and quality of life among transgender people: a systematic review","volume":"5","author":"Baker","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/26895269.2022.2038334","article-title":"Surgical satisfaction and quality of life outcomes reported by transgender men and women at least one year post gender-affirming surgery: a systematic literature review","volume":"23","author":"Javier","year":"2022","journal-title":"Int J Trans Health"},{"issue":"7","key":"10.1016\/j.urolonc.2025.07.017_bib0007","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamasurg.2021.0952","article-title":"Association between gender-affirming surgeries and mental health outcomes","volume":"156","author":"Almazan","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41416-022-01989-y","article-title":"Prostate cancer in transgender women: considerations for screening, diagnosis and management","volume":"128","author":"Crowley","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0009","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/and.12208","article-title":"Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens","volume":"46","author":"Gooren","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2018.02.008","article-title":"Frequency and distribution of primary site among gender minority cancer patients: an analysis of U.S. national surveillance data","volume":"54","author":"Nash","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bju.15521","article-title":"Prostate cancer in transgender women: what does a urologist need to know?","volume":"129","author":"Bertoncelli Tanaka","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2024.06.003","article-title":"Prostate-specific antigen screening for prostate cancer: diagnostic performance, clinical thresholds, and strategies for refinement","volume":"43","author":"Sundaresan","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0013","doi-asserted-by":"crossref","unstructured":"Fenton J.J., Weyrich M.S., Durbin S., Liu Y., Bang H., Melnikow J. Prostate-specific antigen-based screening for Prostate cancer: a systematic evidence review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018. U.S. Preventive Services Task Force evidence syntheses, formerly systematic evidence reviews. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518890\/","DOI":"10.1001\/jama.2018.3712"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0014","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.5489\/cuaj.7851","article-title":"UPDATE \u20132022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging","volume":"16","author":"Mason","year":"2022","journal-title":"CUAJ"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5489\/cuaj.4888","article-title":"Canadian Urological Association recommendations on prostate cancer screening and early diagnosis","volume":"11","author":"Rendon","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0016","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1503\/cmaj.140703","article-title":"Recommendations on screening for prostate cancer with the prostate-specific antigen test","volume":"186","author":"Bell","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0017","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5489\/cuaj.6949","article-title":"Adult transgender care: a review for urologists","volume":"15","author":"Anderson","year":"2021","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0018","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society* clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0019","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/08982643211068557","article-title":"Utilization of recommended preventive health screenings between transgender and cisgender older adults in sexual and gender minority communities","volume":"34","author":"Hoy-Ellis","year":"2022","journal-title":"J Aging Health"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0020","unstructured":"Trans Women. Trans women HIV research [Internet]. 2025. Available from: https:\/\/www.transwomenhivresearch.com\/. Accessed June 4, 2024."},{"key":"10.1016\/j.urolonc.2025.07.017_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/2325958221995612","article-title":"Development of the Canadian women-centred HIV care model using the knowledge-to-action framework","volume":"20","author":"Loutfy","year":"2021","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0024","doi-asserted-by":"crossref","first-page":"e2356088","DOI":"10.1001\/jamanetworkopen.2023.56088","article-title":"Prostate cancer screening uptake in transgender women","volume":"7","author":"Kalavacherla","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1475-6773.2012.01466.x","article-title":"Comparison of Health care utilization: United States versus Canada","volume":"48","author":"Pylypchuk","year":"2013","journal-title":"Health Serv Res"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0026","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.urolonc.2025.07.017_bib0027","article-title":"Prostate specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: findings from cross-sectional survey data","volume":"14","author":"Tchir","year":"2020","journal-title":"CUAJ [Internet]"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03405578","article-title":"Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada","volume":"97","author":"Beaulac","year":"2006","journal-title":"Can J Public Health"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0029","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.eururo.2020.11.009","article-title":"Prostate cancer screening patterns among sexual and gender minority individuals","volume":"79","author":"Ma","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QAI.0000000000000202","article-title":"Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men","volume":"66","author":"Marcus","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0031","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JU.0000000000002249","article-title":"Prostate cancer screening and incidence among aging persons living with HIV","volume":"207","author":"Leapman","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0032","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/aid.2023.0142","article-title":"Receipt of prostate-specific antigen test in medicaid beneficiaries with and without HIV in 2001\u20132015 in 14 states","volume":"40","author":"Pirsl","year":"2024","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0033","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/apc.2019.0013","article-title":"The HIV care cascade among transgender women with HIV in Canada: a mixed-methods study","volume":"33","author":"Lacombe-Duncan","year":"2019","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007428","article-title":"A population-based study comparing patterns of care delivery on the quality of care for persons living with HIV in Ontario","volume":"5","author":"Kendall","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0035","unstructured":"Elisseou S, Potter J. Chapter 13: Performing a trauma-informed physical examination. Transgender and gender diverse health care: the Fenway Guide. USA: McGraw Hill."},{"key":"10.1016\/j.urolonc.2025.07.017_bib0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.2024.9997","article-title":"Prostate-specific antigen values in transgender women receiving estrogen","volume":"332","author":"Nik-Ahd","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0037","unstructured":"Wesp L. UCSF Transgender Care. 2016. Transgender patients and the physical examination | Gender Affirming Health Program. Available from: https:\/\/transcare.ucsf.edu\/guidelines\/physical-examination"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0038","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0039","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12909-020-02409-6","article-title":"Medical students\u2019 awareness of health issues, attitudes, and confidence about caring for lesbian, gay, bisexual and transgender patients: a cross-sectional survey","volume":"21","author":"Arthur","year":"2021","journal-title":"BMC Med Educ"},{"key":"10.1016\/j.urolonc.2025.07.017_bib0040","doi-asserted-by":"crossref","first-page":"424.e1","DOI":"10.1016\/j.urolonc.2015.06.013","article-title":"The influence of physician recommendation on prostate-specific antigen screening","volume":"33","author":"Pucheril","year":"2015","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:16:49Z","timestamp":1772882209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925002741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1078143925002741"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate-specific antigen screening among transgender women in clinical care: A retrospective chart review study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}